Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1995 Aug;88(8):446–449.

The value of antegrade stenting for lower ureteric obstruction.

C N Jenkins 1, A J Marcus 1
PMCID: PMC1295298  PMID: 7562827

Abstract

Eleven kidneys in 10 patients (mean age 80 years) presenting over a period of 1 year with obstruction of the lower ureter secondary to malignant obstruction (8 patients), stone disease (1 patient), and bladder wall hypertrophy (1 patient) underwent nephrostomy with subsequent immediate or delayed antegrade stenting. An antegrade placement of the stent was achieved in 10 of the 11 kidneys (90% success). In three cases a combined procedure was performed with cystoscopic assistance. In most cases there was rapid improvement of renal function following stenting. Insertion of ureteric stents in patients admitted to hospital with malignant ureteric obstruction allowed treatment of their renal failure and subsequent discharge without use of permanent external urinary diversion appliances. No significant complications of the procedure were encountered. Medium term follow-up of patients stented for malignant ureteric obstruction suggests that the stents can be left in place without replacement for up to 20 months.

Full text

PDF
446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson A. F., Mitty H. A. Update on interventional treatment of urinary obstruction. Urol Radiol. 1992;14(3):234–236. doi: 10.1007/BF02926938. [DOI] [PubMed] [Google Scholar]
  2. Andriole G. L., Bettmann M. A., Garnick M. B., Richie J. P. Indwelling double-J ureteral stents for temporary and permanent urinary drainage: experience with 87 patients. J Urol. 1984 Feb;131(2):239–241. doi: 10.1016/s0022-5347(17)50324-9. [DOI] [PubMed] [Google Scholar]
  3. Cardella J. F., Castaneda-Zuniga W. R., Hunter D. W., Hulbert J. C., Amplatz K. Urine-compatible polymer for long-term ureteral stenting. Radiology. 1986 Nov;161(2):313–318. doi: 10.1148/radiology.161.2.3763893. [DOI] [PubMed] [Google Scholar]
  4. Lee W. J., Patel U. Complications of universal ureteral stent. Cardiovasc Intervent Radiol. 1989 Nov;12(6):329–333. doi: 10.1007/BF02575432. [DOI] [PubMed] [Google Scholar]
  5. Mitty H. A., Train J. S., Dan S. J. Placement of ureteral stents by antegrade and retrograde techniques. Radiol Clin North Am. 1986 Dec;24(4):587–600. [PubMed] [Google Scholar]
  6. Mitty H. A. Ureteral stenting facilitated by antegrade transurethral passage of guide wire. AJR Am J Roentgenol. 1984 Apr;142(4):831–832. doi: 10.2214/ajr.142.4.831. [DOI] [PubMed] [Google Scholar]
  7. Rackson M. E., Mitty H. A., Lossef S. V., Dan S. J., Train J. S. Biocompatible copolymer ureteral stent: maintenance of patency beyond 6 months. AJR Am J Roentgenol. 1989 Oct;153(4):783–784. doi: 10.2214/ajr.153.4.783. [DOI] [PubMed] [Google Scholar]
  8. Zadra J. A., Jewett M. A., Keresteci A. G., Rankin J. T., St Louis E., Grey R. R., Pereira J. J. Nonoperative urinary diversion for malignant ureteral obstruction. Cancer. 1987 Sep 15;60(6):1353–1357. doi: 10.1002/1097-0142(19870915)60:6<1353::aid-cncr2820600632>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES